Search research articles
Contact Us
Filters
Showing results (51-60 of 247) with videos related to
Page
of 25
Sort By:
Diabetes Care
|
April 2, 2010
Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study
Bruce A Perkins, Andrej Orszag, Mylan Ngo, et al.
Plos One
|
July 18, 2013
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus
Gary K Yang, David M Maahs, Bruce A Perkins, et al.
Muscle & Nerve
|
August 3, 2023
Reliability of confocal corneal microscopy for measurement of dendritic cell density in suspected small fiber neuropathy
Juan Francisco Idiaquez, Rodrigo Martinez, Carolina Barnett-Tapia, et al.
Diabetes Care
|
December 12, 2007
Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy
Bruce A Perkins, Andrej Orszag, Jaspreet Grewal, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
March 19, 2019
Uric Acid Levels Correlate with Sensory Nerve Function in Healthy Subjects
Alon Abraham, Hans D Katzberg, Leif E Lovblom, et al.
Muscle & Nerve
|
December 23, 2011
Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy
Carolina Barnett, Bruce A Perkins, Mylan Ngo, et al.
Diabetes Technology & Therapeutics
|
November 18, 2006
Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system
Katherine E Iscoe, Jonathan E Campbell, Veronica Jamnik, et al.
Current Diabetes Reports
|
May 28, 2022
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis
Hongyan Liu, Vikas S Sridhar, Bruce A Perkins, et al.
Proteomics
|
September 3, 2021
SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: An in-silico proof-of-principle of proteomics-based drug repurposing
Agnieszka Latosinska, Justyna Siwy, David Z Cherney, et al.
Diabetes, Obesity & Metabolism
|
May 22, 2019
Authors' reply to: "The role of long-term effects of allopurinol on cardiovascular outcomes and all-cause mortality in diabetes"
Alanna Weisman, George A Tomlinson, Lorraine L Lipscombe, et al.
Page
of 25
Search research articles
Search
Showing results (51-60 of 247) with videos related to
Sort By:
Page
of 25
Diabetes Care
|
April 2, 2010
Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study
Bruce A Perkins, Andrej Orszag, Mylan Ngo, et al.
Plos One
|
July 18, 2013
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus
Gary K Yang, David M Maahs, Bruce A Perkins, et al.
Muscle & Nerve
|
August 3, 2023
Reliability of confocal corneal microscopy for measurement of dendritic cell density in suspected small fiber neuropathy
Juan Francisco Idiaquez, Rodrigo Martinez, Carolina Barnett-Tapia, et al.
Diabetes Care
|
December 12, 2007
Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy
Bruce A Perkins, Andrej Orszag, Jaspreet Grewal, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
March 19, 2019
Uric Acid Levels Correlate with Sensory Nerve Function in Healthy Subjects
Alon Abraham, Hans D Katzberg, Leif E Lovblom, et al.
Muscle & Nerve
|
December 23, 2011
Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy
Carolina Barnett, Bruce A Perkins, Mylan Ngo, et al.
Diabetes Technology & Therapeutics
|
November 18, 2006
Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system
Katherine E Iscoe, Jonathan E Campbell, Veronica Jamnik, et al.
Current Diabetes Reports
|
May 28, 2022
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis
Hongyan Liu, Vikas S Sridhar, Bruce A Perkins, et al.
Proteomics
|
September 3, 2021
SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: An in-silico proof-of-principle of proteomics-based drug repurposing
Agnieszka Latosinska, Justyna Siwy, David Z Cherney, et al.
Diabetes, Obesity & Metabolism
|
May 22, 2019
Authors' reply to: "The role of long-term effects of allopurinol on cardiovascular outcomes and all-cause mortality in diabetes"
Alanna Weisman, George A Tomlinson, Lorraine L Lipscombe, et al.
Page
of 25